Litcius/Paper detail

TRIM29 promotes glioblastoma progression via ubiquitinating NEFL and activating the PI3K/AKT signaling pathway

Y. Liu, Qisheng He, Lingjie Zhu, Mengmeng Zhong, Hao Zhuang, Ning Zhao, Yijin Cai, Chao Cheng, Junfei Shao

2025Cancer Genetics6 citationsDOI

Topics & Concepts

GlioblastomaProtein kinase BPI3K/AKT/mTOR pathwayCancer researchSignal transductionBiologyCell biologyinterferon and immune responsesProtein Degradation and InhibitorsUbiquitin and proteasome pathways
TRIM29 promotes glioblastoma progression via ubiquitinating NEFL and activating the PI3K/AKT signaling pathway | Litcius